Tech Company Financing Transactions

BlossomHill Therapeutics Funding Round

Cormorant Asset Management, OrbiMed and Vivo Capital joined a $71 million Series A funding round for BlossomHill Therapeutics. This VC investment round was announced by the company on 3/5/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

6370 Lusk Blvd. F205
San Diego, CA 92121
USA

Phone

Undisclosed

Website

www.bhtherapeutics.com

Email Address

[email protected]

Overview

BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Yishan Li

        

Chief Executive Officer

Jingrong Cui

        

Browse more venture capital transactions:

Prev: 3/5/2021: Doppler venture capital transaction
Next: 3/5/2021: Snapcommerce venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary